Silver Book Fact

It is estimated that proper treatment and monitoring of the eyes of diabetics could reduce new cases of diabetic retinopathy by 90%.

Tapp R, Shaw J, Harper C, P de Courten M, et al. The Prevalence of and Factors Associated with Diabetic Retinopathy in the Australian Population. Diabetes Care. 2003; 26(6): 1731-1737. http://care.diabetesjournals.org/content/26/6/1731

Reference

Title
The Prevalence of and Factors Associated with Diabetic Retinopathy in the Australian Population
Publication
Diabetes Care
Publication Date
2003
Authors
Tapp R, Shaw J, Harper C, P de Courten M, et al
Volume & Issue
Volume 26, Issue 6
Pages
1731-1737
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Anti-VEGF Visual Improvement
    Nearly 50% of DME patients who received an anti-VEGF drug, experienced substantial visual improvement after a year of injections.  
  • Gene transfer process treatment for diabetic retinopathy
    A gene transfer process that produces a VEGF receptor prevents retinal vascular permeability (RVP) associated with diabetes that could have value in treating diabetic retinopathy.  
  • Screening and treatment for eye disease in all type 2 diabetes patients would result in an estimated net savings of 94,304 person-years of sight.  
  • The NEI-sponsored Age-Related Eye Disease Study (AREDS) found that individuals at high risk of developing advanced stages of age-related macular degeneration (AMD) lowered their risk of disease progression by about…  
  • Multifocal electroretinogram (mFERG) and flicker perimetry show abnormal function in the central macula in early ag-related macular degeneration (AMD) and could enhance monitoring of the disease progression in individuals.